MedTrace Logo

Evaluation of Fuling Yunhua Granules and Dihuang Baoyuan Granules in Drug Naive Type 2 Diabetes Patients

NCT06575478 · Status: RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2024-08-28

No results posted yet for this study

Summary

The goal of this investigator-initiated clinical trial is to investigate the efficacy and safety of sequential therapy of Fuling Yunhua Granules (prescription A) and Dihuang Baoyuan Granule (prescription B) in the treatment of type 2 diabetes patients with poor glycemic control after diet and exercise intervention.

Conditions

  • Diabetes Mellitus, Type 2
  • Diabetes
  • Type2diabetes

Interventions

DRUG

Fuling Yunhua Granules

Fuling Yunhua Granules

DRUG

Fuling Yunhua Granules matched placebo

Fuling Yunhua Granules placebo

DRUG

Dihuang Baoyuan Granules

Dihuang Baoyuan Granules

DRUG

Dihuang Baoyuan Granules matched placebo

Dihuang Baoyuan Granules placebo

Sponsors & Collaborators

  • Peking University People's Hospital

    collaborator OTHER

  • Beijing Supreme Life Pharmaceutical Technology Co., Ltd.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-07-31
Primary Completion
2025-01-30
Completion
2025-01-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06575478 on ClinicalTrials.gov